BMC
EW icon

Benin Management Corp’s Edwards Lifesciences EW Stock Holding History

Benin Management Corp’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369K Sell
4,076
-200
-5% -$16.8K 0.07% 114
2026
Q1 		$342K Hold
4,276
– – 0.08% 106
2025
Q4 		$365K Sell
4,276
-500
-10% -$41K 0.08% 101
2025
Q3 		$371K Hold
4,776
– – 0.09% 96
2025
Q2 		$374K Hold
4,776
– – 0.1% 91
2025
Q1 		$346K Buy
4,776
+33
+0.7% +$2.36K 0.1% 91
2024
Q4 		$351K Hold
4,743
– – 0.1% 89
2024
Q3 		$313K Sell
4,743
-350
-7% -$25.4K 0.09% 97
2024
Q2 		$470K Buy
5,093
+43
+0.9% +$3.81K 0.14% 74
2024
Q1 		$483K Sell
5,050
-6
-0.1% -$504 0.15% 66
2023
Q4 		$386K Sell
5,056
-1,344
-21% -$93.5K 0.13% 73
2023
Q3 		$443K Hold
6,400
– – 0.16% 62
2023
Q2 		$604K Sell
6,400
-1,500
-19% -$130K 0.22% 55
2023
Q1 		$654K Hold
7,900
– – 0.25% 51
2022
Q4 		$589K Buy
7,900
+5,400
+216% +$416K 0.24% 53
2022
Q3 		$207K Hold
2,500
– – 0.09% 89
2022
Q2 		$238K Buy
2,500
+700
+39% +$72.5K 0.09% 88
2022
Q1 		$212K Sell
1,800
-2,800
-61% -$314K 0.07% 101
2021
Q4 		$596K Hold
4,600
– – 0.18% 66
2021
Q3 		$521K Sell
4,600
-2,400
-34% -$274K 0.17% 68
2021
Q2 		$725K Sell
7,000
-100
-1% -$9.43K 0.23% 53
2021
Q1 		$594K Buy
7,100
+3,700
+109% +$313K 0.21% 56
2020
Q4 		$310K Buy
+3,400
New +$282K 0.12% 77
2018
Q1 		– Sell
-15,900
Closed -$597K – 95
2017
Q4 		$597K Hold
15,900
– – 0.24% 56
2017
Q3 		$579K Hold
15,900
– – 0.23% 56
2017
Q2 		$627K Hold
15,900
– – 0.27% 50
2017
Q1 		$499K Hold
15,900
– – 0.23% 60
2016
Q4 		$497K Buy
15,900
+1,500
+10% +$48.6K 0.23% 62
2016
Q3 		$579K Hold
14,400
– – 0.28% 53
2016
Q2 		$479K Hold
14,400
– – 0.25% 64
2016
Q1 		$423K Hold
14,400
– – 0.23% 64
2015
Q4 		$379K Hold
14,400
– – 0.21% 64
2015
Q3 		$341K Hold
14,400
– – 0.19% 70
2015
Q2 		$342K Hold
14,400
– – 0.18% 71
2015
Q1 		$342K Hold
14,400
– – 0.18% 72
2014
Q4 		$306K Sell
14,400
-12,300
-46% -$247K 0.16% 77
2014
Q3 		$455K Sell
26,700
-28,800
-52% -$455K 0.23% 64
2014
Q2 		$794K Sell
55,500
-19,200
-26% -$260K 0.43% 45
2014
Q1 		$923K Sell
74,700
-6,660
-8% -$76.8K 0.56% 37
2013
Q4 		$892K Sell
81,360
-36,600
-31% -$413K 0.56% 42
2013
Q3 		$1.37M Buy
117,960
+57,960
+97% +$678K 0.84% 31
2013
Q2 		$672K Buy
+60,000
New +$710K 0.41% 49

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $1.85B AUM 62.46% 1-Year Est. Return

Benin Management Corp's EW Position: Q2 2026 in Review

Benin Management Corp reduced its Edwards Lifesciences (EW) stake by 4.7% in Q2 2026, selling an estimated $16.8K and leaving 4,076 shares worth $369K. The position accounts for 0.07% of the portfolio, ranked #114.

Benin Management Corp first reported a position in EW in Q2 2013 and has held it in 42 quarters since. The position peaked at $1.37M in Q3 2013. 230 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Benin Management Corp held 4,076 shares of Edwards Lifesciences worth $369K as of Q2 2026.
  • Benin Management Corp sold 200 Edwards Lifesciences shares in Q2 2026, an estimated $16.8K.
  • Edwards Lifesciences made up 0.07% of Benin Management Corp's portfolio in Q2 2026, its #114 holding.
  • Benin Management Corp first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 42 quarters since.
  • Benin Management Corp's Edwards Lifesciences position peaked at $1.37M in Q3 2013.
  • 230 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Benin Management Corp's 13F filing for Q2 2026, filed 15 Jul 2026.